Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, ...

The biopharmaceutical field leads the way in science, researching and developing new treatments for health needs. In 2024, research and development in this area will face fast changes, bringing both ...

Safety and efficacy of two candidates are currently being assessed in investigator-initiated clinical trials. BRC is planning to commence enrollment for Phase 2 and 3 trials by mid 2026. MONTEREY, ...

Below is a summary assembled by the Research & Innovation Office (RIO). Please see the Tang Prize website for complete information. The Tang Prize comprises four categories, namely Sustainable ...

The students, faculty and researchers involved in biopharmaceutical sciences at the University take an interdisciplinary approach to addressing grand challenges of healthcare, medicine and ...

The drug development process is driven by both medical need and business opportunity. The process itself is arduous, expensive and time-consuming. Invariably, it takes not only expertise, but robust ...

University of Delaware leaders, Delaware’s Congressional delegation and members of the life sciences industry gathered Monday, April 22, to mark the next chapter in the development of the Securing ...

Oklahoma City, OK -- Cytovance Biologics, Inc. and Fountain BioPharma, Inc. jointly announce the execution of a Biopharmaceutical Development and Manufacturing collaboration for FB301, a novel ...

In process monitoring is important for optimizing cell culture conditions such as nutrient concentrations, cell viability, and metabolite production as well as product quality attributes such as ...

The biopharmaceutical industry faces strict regulations worldwide, making it essential to meet international standards before any new therapy can enter the market. Staying informed about the current ...

Emerging technologies like artificial intelligence (AI) and machine learning (ML) are making their mark on every aspect of our lives. Biopharmaceutical companies are beginning to leverage both ...

CINCINNATI & SHANGHAI--(BUSINESS WIRE)--LIB Therapeutics Inc. (“LIB”) and Hasten Biopharmaceutical Co., Ltd. (“Hasten”), today announce that the companies have entered into an agreement granting ...